Resumo | Inibidores de SGLT2 e de agonistas receptores de GLP-1: Indicações novas e as já estabelecidas.
14 Jul, 2021 | 11:24hSGLT2 Inhibitors and GLP-1 Receptor Agonists: Indications – American College of Cardiology
Revisão original: SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications – The Lancet (link para o resumo – $ para o texto completo)